Research
A nationally recognized, comprehensive program dedicated to the conduct of basic, translational, clinical, and population-based research in advancing the understanding, diagnosis, and treatment of cancer and hematological disorders
Education and Training
Our mission is to train the next generation of cancer researchers and clinical leaders by providing clinical inpatient and outpatient practice education along with research training under the supervision of world-renowned specialists
Clinical
Internationally recognized for our leadership in the prevention, detection, diagnosis, and treatment of cancer. We are committed to meeting the highest standards of cancer care and providing the most advanced treatments.
Division strongly represented at annual ASH meeting in New Orleans
Division of Hematology Oncology residents, trainees and faculty are strongly represented at this year's annual meeting of the American Society of Hematology (ASH) held in New Orleans, Louisiana, December 10-13, 2022, presenting their translational, clinical and basic...
Fall 2022 Research Highlights
Highlighted Publications A Phase 1 Dose Escalation Study of the Pyruvate Kinase Activator Mitapivat (AG-348) in Sickle Cell Disease. In this Phase 1 single-center, open-label study of the novel red-cell pyruvate kinase (PKR) activator mitapivat (AG-348) for the...
Dr. Taofeek Owonikoko Named Chief of the Division of Hematology/Oncology
Taofeek K. Owonikoko, MD, PhD, will join the Department of Medicine as chief of the Division of Hematology/Oncology. Owonikoko, a physician-scientist board-certified in medical oncology, hematology and internal medicine, will begin his appointment on July 1, 2021.
Contact Us
Division of Hematology/Oncology
Administrative/Academic Offices
UPMC Cancer Pavilion
5150 Centre Avenue, 5th floor
Pittsburgh, PA 15232
412-648-6575 | Email Us
UPMC Hillman Cancer Center
Outpatient Services
5115 Centre Avenue
Pittsburgh, PA 15232
412-692-4724